BCAB 8-K 2026-10-20

BioAtla, Inc. (BCAB) 8-K dated 2026-10-20 — accession 0001193125-26-425553.

BioAtla, Inc. (BCAB) is a biotechnology company listed on NASDAQ.

BioAtla, Inc. filed a 8-K on 2026-10-20. Accession 0001193125-26-425553.

This 8-K covers: Material agreement (Item 1.01), Agreement ended (Item 1.02), Unregistered share sale (Item 3.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported BCAB revenue for 2023-09-30 was $0. Net income was -$33.3M. BCAB currently screens at market cap $5.9M.

Not investment advice. The BCAB SEC hub lists recent forms. The stock page is the research view.